Enlicitide for Healthy Participants

This trial explores how the body processes different types of enlicitide, a medication, under various conditions, such as after a high-fat meal or on an empty stomach. Participants will receive one of several enlicitide formulations to observe how each behaves in the body. The study seeks healthy individuals with a BMI between 18 and 32 who have no history of serious digestive issues, cancer, or certain infections like HIV or hepatitis. As a Phase 1 trial, this research aims to understand how the treatment works in people, offering participants the opportunity to be among the first to receive this new medication.

A previous study did not provide specific safety information for enlicitide. As this is an early-phase trial, the main goal is to assess the treatment's safety for people. Early-phase trials typically serve as the initial step in testing a new treatment in humans. These trials help determine the treatment's safety and the appropriate dose. Researchers closely monitor participants for any side effects or unexpected medical issues. This careful observation helps gather important safety information about the treatment.¹²³⁴⁵

Enlicitide is unique because it is an investigational treatment being explored for its different formulations and how they perform under fed and fasted conditions. Unlike typical treatments that may not specify dietary conditions, enlicitide's trials are examining its effectiveness and absorption with or without a high-fat meal. Researchers are excited because understanding how enlicitide behaves in these conditions could lead to more personalized and effective dosing recommendations, potentially enhancing its efficacy and safety profile compared to existing options.

Research has shown that enlicitide, a pill designed to lower bad cholesterol (LDL-C), works by blocking a protein called PCSK9, which typically maintains high cholesterol levels. Studies have found that regular use of enlicitide can reduce LDL-C levels by 57–65%. This treatment matches the effectiveness of injectable medications but offers the convenience of a pill. As a result, it presents a promising option for managing cholesterol. In this trial, participants will receive different formulations of enlicitide under various conditions to evaluate its effectiveness and safety.⁶⁷⁸⁹¹⁰